EKF Diagnostics (LON:EKF) Stock Price Crosses Above 200 Day Moving Average of $28.41

EKF Diagnostics Holdings plc (LON:EKF) shares crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 28.41 ($0.35) and traded as high as GBX 28.72 ($0.35). EKF Diagnostics shares last traded at GBX 27.80 ($0.34), with a volume of 183,640 shares traded.

EKF Diagnostics Price Performance

The company has a 50 day moving average of GBX 27.39 and a 200-day moving average of GBX 28.41. The stock has a market capitalization of £126.14 million, a P/E ratio of 2,780.00 and a beta of 0.58. The company has a quick ratio of 1.77, a current ratio of 2.69 and a debt-to-equity ratio of 6.01.

Insider Buying and Selling

In related news, insider Christopher H. B. Mills bought 100,000 shares of the business’s stock in a transaction on Friday, March 22nd. The shares were bought at an average cost of GBX 26 ($0.32) per share, for a total transaction of £26,000 ($32,114.62). 5.11% of the stock is currently owned by company insiders.

EKF Diagnostics Company Profile

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.